These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 24794492
1. Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Song GG, Bae SC, Lee YH. Clin Rheumatol; 2014 Dec; 33(12):1715-24. PubMed ID: 24794492 [Abstract] [Full Text] [Related]
2. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis. Lee YH, Song GG. Clin Drug Investig; 2010 Dec; 30(2):101-8. PubMed ID: 20067328 [Abstract] [Full Text] [Related]
3. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Shao W, Yuan Y, Li Y. Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784 [Abstract] [Full Text] [Related]
4. Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis. Choe JY, Lee H, Jung HY, Park SH, Bae SC, Kim SK. Rheumatol Int; 2012 Jun; 32(6):1837-42. PubMed ID: 21773884 [Abstract] [Full Text] [Related]
6. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Saleh MM, Irshaid YM, Mustafa KN. Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850 [Abstract] [Full Text] [Related]
7. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis. Yuan Y, Shao W, Li Y. Rheumatol Int; 2017 Apr; 37(4):557-569. PubMed ID: 28175955 [Abstract] [Full Text] [Related]
8. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population. Cáliz R, del Amo J, Balsa A, Blanco F, Silva L, Sanmarti R, Martínez FG, Collado MD, Ramirez Mdel C, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Andreu JL, Graell E, Simon L, Martínez A, Mulero J. Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028 [Abstract] [Full Text] [Related]
9. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA. OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111 [Abstract] [Full Text] [Related]
10. Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis. Fan H, Li Y, Zhang L, Li Y, Li W. Int J Rheum Dis; 2017 May; 20(5):526-540. PubMed ID: 28544525 [Abstract] [Full Text] [Related]
11. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Owen SA, Lunt M, Bowes J, Hider SL, Bruce IN, Thomson W, Barton A. Pharmacogenomics J; 2013 Apr; 13(2):137-47. PubMed ID: 21931346 [Abstract] [Full Text] [Related]
12. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients. Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J. Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758 [Abstract] [Full Text] [Related]
13. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A. Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376 [Abstract] [Full Text] [Related]
14. Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis. Spyridopoulou KP, Dimou NL, Hamodrakas SJ, Bagos PG. Pharmacogenet Genomics; 2012 Feb; 22(2):117-33. PubMed ID: 22143415 [Abstract] [Full Text] [Related]
15. Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis. Wang S, Zuo S, Liu Z, Ji X, Yao Z, Wang X. J Int Med Res; 2020 Feb; 48(2):300060519879588. PubMed ID: 31617429 [Abstract] [Full Text] [Related]
16. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway. Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, Keskes L, Fourati H, Bahloul Z, Maalej A. Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125 [Abstract] [Full Text] [Related]
17. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients. Chaabane S, Messedi M, Akrout R, Ben Hamad M, Turki M, Marzouk S, Keskes L, Bahloul Z, Rebai A, Ayedi F, Maalej A. Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841 [Abstract] [Full Text] [Related]
18. Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases. Mena JP, Salazar-Páramo M, González-López L, Gámez-Nava JI, Sandoval-Ramirez L, Sánchez JD, Figuera LE, Muñoz-Valle FJ, Vazquez del Mercado M, Dávalos IP. Pharmacogenomics J; 2011 Aug; 11(4):287-91. PubMed ID: 20514079 [Abstract] [Full Text] [Related]
19. Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients. Urano W, Furuya T, Inoue E, Taniguchi A, Urano T, Kotake S, Sekita C, Inoue S, Hara M, Momohara S, Kamatani N, Yamanaka H. J Bone Miner Metab; 2009 Aug; 27(5):574-83. PubMed ID: 19333678 [Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate. Kim SK, Jun JB, El-Sohemy A, Bae SC. J Rheumatol; 2006 Jul; 33(7):1266-74. PubMed ID: 16758511 [Abstract] [Full Text] [Related] Page: [Next] [New Search]